- Home
- AEON vs EVOK Comparison
AEON vs EVOK Comparison
Compare AEON & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEON
- EVOK
- Stock Information
- Founded
- AEON N/A
- EVOK 2007
- Country
- AEON United States
- EVOK United States
- Employees
- AEON N/A
- EVOK N/A
- Industry
- AEON Biotechnology: Pharmaceutical Preparations
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- AEON Health Care
- EVOK Health Care
- Exchange
- AEON Nasdaq
- EVOK Nasdaq
- Market Cap
- AEON 4.2M
- EVOK 4.2M
- IPO Year
- AEON N/A
- EVOK 2013
- Fundamental
- Price
- AEON $0.46
- EVOK $2.59
- Analyst Decision
- AEON Strong Buy
- EVOK
- Analyst Count
- AEON 1
- EVOK 0
- Target Price
- AEON $360.00
- EVOK N/A
- AVG Volume (30 Days)
- AEON 465.0K
- EVOK 16.5K
- Earning Date
- AEON 05-13-2025
- EVOK 05-13-2025
- Dividend Yield
- AEON N/A
- EVOK N/A
- EPS Growth
- AEON N/A
- EVOK N/A
- EPS
- AEON 72.93
- EVOK N/A
- Revenue
- AEON N/A
- EVOK $10,249,415.00
- Revenue This Year
- AEON N/A
- EVOK $58.84
- Revenue Next Year
- AEON N/A
- EVOK $58.11
- P/E Ratio
- AEON $0.01
- EVOK N/A
- Revenue Growth
- AEON N/A
- EVOK 97.84
- 52 Week Low
- AEON $0.38
- EVOK $1.94
- 52 Week High
- AEON $402.48
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- AEON 26.87
- EVOK 47.70
- Support Level
- AEON $0.38
- EVOK $2.02
- Resistance Level
- AEON $0.43
- EVOK $2.53
- Average True Range (ATR)
- AEON 0.04
- EVOK 0.22
- MACD
- AEON 0.20
- EVOK 0.10
- Stochastic Oscillator
- AEON 56.29
- EVOK 97.01
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.